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Abstract 
Background: Global epigenetic reprogramming is considered to be essential during embryo development to 
establish totipotency. In the classic model first described in the mouse, the genome-wide DNA demethylation is 
asymmetric between the paternal and the maternal genome. The paternal genome undergoes ten-eleven transloca-
tion (TET)-mediated active DNA demethylation, which is completed before the end of the first cell cycle. Since TET 
enzymes oxidize 5-methylcytosine to 5-hydroxymethylcytosine, the latter is postulated to be an intermediate stage 
toward DNA demethylation. The maternal genome, on the other hand, is protected from active demethylation and 
undergoes replication-dependent DNA demethylation. However, several species do not show the asymmetric DNA 
demethylation process described in this classic model, since 5-methylcytosine and 5-hydroxymethylcytosine are 
present during the first cell cycle in both parental genomes. In this study, global changes in the levels of 5-methylcy-
tosine and 5-hydroxymethylcytosine throughout pronuclear development in equine zygotes produced in vitro were 
assessed using immunofluorescent staining.
Results: We were able to show that 5-methylcytosine and 5-hydroxymethylcytosine both were explicitly present 
throughout pronuclear development, with similar intensity levels in both parental genomes, in equine zygotes 
produced by ICSI. The localization patterns of 5-methylcytosine and 5-hydroxymethylcytosine, however, were differ-
ent, with 5-hydroxymethylcytosine homogeneously distributed in the DNA, while 5-methylcytosine tended to be 
clustered in certain regions. Fluorescence quantification showed increased 5-methylcytosine levels in the maternal 
genome from PN1 to PN2, while no differences were found in PN3 and PN4. No differences were observed in the 
paternal genome. Normalized levels of 5-hydroxymethylcytosine were preserved throughout all pronuclear stages in 
both parental genomes.
Conclusions: In conclusion, the horse does not seem to follow the classic model of asymmetric demethylation as 
no evidence of global DNA demethylation of the paternal pronucleus during the first cell cycle was demonstrated. 
Instead, both parental genomes displayed sustained and similar levels of methylation and hydroxymethylation 
throughout pronuclear development.
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Background
During mammalian development, two major waves of 
epigenetic reprogramming take place, one during germ 
line differentiation and the second during preimplanta-
tion embryo development. The epigenetic reprogram-
ming during embryo development is of major importance 
because it is considered as being essential to establish a 
totipotent state [1]. The methylation of the fifth carbon 
of cytosine, 5-methylcytosine (5mC), was the first epi-
genetic modification discovered in DNA and, hence, is 
nowadays the best studied DNA epigenetic modifica-
tion. It plays a key role in gene expression regulation, X 
chromosome inactivation, gene imprinting and the con-
trol of endogenous retrotransposons [2]. Based on stud-
ies in the mouse, the genome-wide DNA demethylation 
during embryo development, which excludes imprinted 
genes and retrotransposons, is proposed to be asymmet-
ric between the maternal and the paternal genome [3, 
4]. As such, the complete demethylation of the paternal 
DNA is achieved before the end of the first cell cycle by 
active demethylation. In contrast, the demethylation of 
the maternal genome is a passive process associated with 
cell divisions [5]. This epigenetic reprogramming during 
preimplantation embryo development, however, is not 
strictly conserved between species. While this asymmet-
ric global demethylation pattern is conserved in rat [2, 6] 
and human [7], some species such as rabbit [8], pig [9], 
goat [10] and sheep [11] failed to follow this model. In 
these species, no DNA demethylation is observed during 
the first cell cycle, regardless of the parental origin of the 
genome. Other species, such as cattle, show an interme-
diate pattern with partial demethylation of the paternal 
pronucleus (pPN) in the zygote [11].
In 2009, a new modified form of cytosine, 5-hydroxy-
methylcytosine (5hmC), was identified. This new modi-
fication is generated by the oxidation of 5mC by the 
ten-eleven translocation (TET) enzymes [12, 13], which 
are able to further oxidize 5hmC into 5-formylcytosine 
(5fC) and 5-carboxylcytosine (5caC) [12]. As such, TET3 
is considered to be the initiator of active DNA demeth-
ylation in the paternal genome. The protein STELLA 
(PGC7), on the other hand, protects the maternal 
genome from active demethylation by binding to the di-
methylated histone H3 lysine 9 (H3K9me2) and exclud-
ing TET3 which results in preventing the oxidation of 
5mC to 5hmC [14]. The fact that 5hmC was considered 
then a DNA demethylation transient, was supported 
by the observed complementary patterns of 5mC and 
5hmC in the pPN during pronuclear development in 
mouse, rabbit and cattle, in which a reduction in 5mC 
levels is accompanied by an increase in 5hmC levels [15]. 
Though, the presence of high 5hmC levels in several tis-
sues, including the nervous system, indicates that this 
epigenetic DNA modification plays its own epigenetic 
role [13] being involved in chromatin and transcription 
regulation [16, 17].
The biological implication of this lack of interspecies 
conservation of global asymmetric DNA demethyla-
tion is currently unknown. Moreover, the contradictory 
results observed within the same species using differ-
ent immunofluorescent staining protocols [16–19] have 
questioned the model as well. In this study, we aimed to 
gain further insight into the interspecies conservation of 
5mC and 5hmC patterns during the first cell cycle. To 
this end, we characterized for the first time the dynamics 
of 5mC and 5hmC throughout pronuclear development 
in equine zygotes produced by ICSI, independently in 
the maternal (mPN) and the paternal (pPN) pronucleus, 
using an immunofluorescent staining protocol optimized 
previously [20, 21].
Results
Zygote classification according to pronuclear morphology
In this study, the dynamic patterns of 5mC and 5hmC 
were analyzed independently for the pPN and the mPN 
during pronuclear development in in  vitro-produced 
equine zygotes. To this end, the zygotes (n = 141) were 
classified into different stages according to size, position 
and conformation of the pronuclei. Due to the lipid-rich 
cytoplasm of equine oocytes and zygotes, immunostain-
ing was used to identify the following pronuclear stages: 
(1) PN0: decondensing sperm head and meiosis II fin-
ished with the second polar body extruded and the 
chromosomes which start to decondense, (2) PN1: the 
decondensed DNA of the mPN and pPN is forming two 
small pronuclei, (3) PN2: the pronuclei are increasing in 
size and start to migrate toward the center, (4) PN3: the 
pronuclei reached their maximum size and are in apposi-
tion and (5) PN4: the pronuclei are in apposition and dis-
play an area with a fibrillary aspect.
To obtain all pronuclear stages, equine zygotes were 
collected at five time points ranging from 8 to 23 h after 
fertilization using intracytoplasmic sperm injection 
(ICSI). The distribution of the pronuclear and cleav-
age stages among the different collection time points is 
illustrated in Fig. 1. As the oocytes were fertilized using 
ICSI, the moment of penetration of the spermatozoon 
was timed precisely. Nevertheless, a lot of variability in 
the developmental stage of the embryos within each col-
lection time point was observed, indicating that the acti-
vation of the oocyte and further pronuclear formation in 
the individual embryos were not evolving synchronously.
The oocyte activation rate increased with time in cul-
ture (h). The shortest activation rate was observed at 8 h 
after ICSI, with less than 40% of the injected oocytes acti-
vated, while 75.5% was activated at 23  h after ICSI, i.e., 
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the last time point of collection. At 8 h after ICSI, most 
zygotes were identified as PN1 (11%) and PN2 (18%) 
stages. At 11 h after ICSI, the majority of zygotes were at 
PN2 stage (27%), with only 8% and 3% at PN1 and PN3, 
respectively. At 15 h after ICSI, PN2 (26%) was again the 
most observed stage although 22% of the collected zygotes 
were in PN3. At 19 h after ICSI, zygotes were still mostly 
in PN2 (31%), while 15% of the zygotes were in either PN3 
or PN4. At 23 h after ICSI, only 16% of the zygotes were 
in PN2 and PN3 became the most common stage (27%). 
Within these last two time points of collection, i.e., 19 
and 23 h after ICSI, 5% and 10% of the embryos already 
reached the two-cell stage, respectively. Furthermore, 23 h 
after ICSI, 4% of the embryos were at the four-cell stage. 
PN1 might be considered as a very transitory stage as it 
was only observed in 19 of the 141 zygotes included in the 
study, while PN2, the stage in which the pronuclei grow 
and migrate, was present at all collection time points and 
can be considered as the longest stage with 59 of the 141 
zygotes observed in that stage.
Determination of the parental pronuclear origin and DNA 
content
In the mouse, the relative pronuclear size is used to 
determine the parental origin of the pronuclei [22, 23]. 
However, the relative size of the pronuclei in the horse 
is variable and does not differ between the mPN and 
pPN, as confirmed in this study (Fig.  2). Therefore, the 
asymmetric pattern of the tri-methylation of histone H3 
lysine 9 (H3K9me3) was used to accurately differentiate 
between the mPN and pPN. This histone modification is 
in the horse only present in the mPN throughout pronu-
clear development, as described previously [20].
After determination of the stage and parental origin of 
the pronuclei, the total DNA fluorescence was calculated 
for each pronucleus of each zygote by multiplying the 
fluorescence intensity by its corresponding pronuclear 
area. When the total DNA fluorescence between the dif-
ferent pronuclear stages was compared independently 
for the mPN and the pPN (Fig. 3), a significant increase 
was observed between PN1 and PN2 in the mPN (p 
Fig. 1 Distribution of ICSI-produced equine embryos among developmental stages in each time point of collection. The time points of collection 
are measured in hours after ICSI (hpi). The oocytes in metaphase II (MII) did not activate after the injection of the spermatozoon, which was found 
intact in the cytoplasm of the oocyte. The number of injected oocytes collected at each time point is indicated in the right. Degenerated oocytes 
and zygotes were excluded from the analysis
Fig. 2 Evolution of the pronuclear size during development. No dif-
ferences were found in mean pronuclear size (at the largest diameter) 
between the mPN and pPN in the four pronuclear stages. PN1 n = 19, 
PN2 n = 59, PN3 n = 37, PN4 n = 26. Error bars represent ±1 SD
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value = 0.01) and between PN1 and PN3 in the pPN (p 
value = 0.01), which is indicative for DNA replication. In 
the rabbit, it has been demonstrated that DNA replica-
tion occurs during the migration and enlargement of the 
pronuclei (PN2 and PN3 of their classification) by inject-
ing DIG-11dUTP in the zygotes [24]. Consequently, the 
total fluorescence of 5mC or 5hmC was divided by its 
corresponding total DNA fluorescence, as performed by 
Reis Silva et al. [24], to correct for the DNA replication 
that occurs during pronuclear development [25].
Dynamics of DNA methylation during pronuclear 
development
The global DNA methylation pattern of 60 ICSI-pro-
duced equine zygotes was analyzed throughout pro-
nuclear development (PN1: n  =  6, PN2: n  =  25, PN3: 
n = 18, PN4: n = 11).
5mC was highly present in both the mPN and the pPN 
and no differences in intensity could be determined at a 
glance between the mPN and the pPN (Fig. 4). Interest-
ingly, the distribution of 5mC in the pronuclei was rather 
heterogeneous with higher concentrations in certain 
regions of the DNA (Fig. 5a).
The dynamics of the normalized 5mC fluorescence 
(5mC/DNA) between the different pronuclear stages 
showed a significant increase between PN1 and PN2 in 
the mPN (p value =  0.022) (Fig.  6). In the pPN, on the 
other hand, no significant differences in normalized 5mC 
fluorescence were observed between pronuclear stages. 
Regarding total 5mC fluorescence, a significant increase 
was found between PN1 and PN2, PN3, and PN4 in the 
mPN (p value = 0.015, 0.003 and 0.011, respectively) and 
between PN1 and PN2 in the pPN (p value = 0.032). The 
total DNA fluorescence increased significantly between 
PN1 and PN3 (p value  =  0.023) in the mPN, but the 
increase in DNA fluorescence observed in the pPN 
when all zygotes included in the study were taken into 
account (5mC + 5hmC: n = 141) (Fig. 3) did not reach 
statistical significance when only the 5mC-stained pPN 
(n = 60) was considered (Fig. 6). Finally, higher normal-
ized 5mC fluorescence was observed in the mPN than in 
the pPN at PN3, with a paternal/maternal ratio of 0.83 (p 
value = 0.046).
Dynamics of DNA hydroxymethylation during pronuclear 
development
To evaluate the global hydroxymethylation pattern in 
equine zygotes, 81 zygotes were produced using ICSI and 
distributed in four pronuclear stages (PN1: n = 13, PN2: 
n = 34, PN3: n = 19, PN4: n = 15).
In all the zygotes analyzed, 5hmC was highly pre-
sent throughout pronuclear development in both 
the pPN and mPN, with no observable differences 
depending on the parental pronuclear origin (Fig.  7). 
In contrast to the distribution of 5mC, 5hmC was 
very homogeneously distributed in the DNA (Fig. 5b). 
After quantifying the fluorescence intensity, no sig-
nificant differences were observed in the normalized 
Fig. 3 Total DNA fluorescence of the paternal (pPN) and maternal (mPN) pronucleus in each pronuclear stage. Comparisons were made between 
the different pronuclear stages independently for the pPN and the mPN; 141 zygotes were included in the study (PN1 n = 19, PN2 n = 59, PN3 
n = 37 and PN4 n = 26). In the pPN, significant differences were observed between PN1 and PN3-PN4. In the mPN, significant differences were 
found between PN1 and PN2-PN3-PN4. The data were analyzed with SPSS Statistics 24, by the Kruskal–Wallis H test combined with Bonferroni cor-
rection for multiple testing. Different superscripts (a or b) indicate significant differences, and p values <0.05 were considered significant
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5hmC levels (5hmC/DNA) between pronuclear 
stages regardless the parental origin of the pronuclei 
(Fig.  8), indicating that the ratio of 5hmC to DNA is 
relatively constant throughout pronuclear develop-
ment. The total 5hmC fluorescence showed a signifi-
cant increase between PN1 and PN2, PN3 and PN4 
(p value = 0.025, 0.009 and 0.004, respectively) in the 
mPN, and between PN1 and PN3 (p value = 0.008) in 
the pPN (Fig.  8). Analogously, the total DNA fluores-
cence between pronuclear stages also increased signif-
icantly between PN1 and PN3-PN4 in both the mPN (p 
value = 0.001) and the pPN (p value = 0.01 and 0.002, 
respectively). These results indicate that the increase 
in 5hmC is associated with the increase in DNA. Sig-
nificantly lower levels of normalized 5hmC were 
found in the pPN compared to the mPN in PN2, with a 
paternal/maternal ratio of 0.87 (p value = 0.027). The 
opposite situation was observed in PN3, with signifi-
cantly higher levels of normalized 5hmC in the pPN 
compared to the mPN and a paternal/maternal ratio of 
1.25 (p value = 0.027).
Discussion
In this study, we analyzed for the first time the global 
dynamic patterns of 5mC and 5hmC independently for 
the pPN and the mPN during pronuclear development in 
equine zygotes produced by ICSI.
To evaluate the dynamic changes in 5mC and 5hmC 
during pronuclear development, equine zygotes were col-
lected at five different time points within the first 23  h 
after ICSI. Within this time frame, we were able to assess 
the whole pronuclear development as the embryo stages 
collected ranged from injected oocytes, which were not 
activated yet to four-cell embryos.
Fig. 4 5-Methylcytosine (5mC) patterns in the maternal (mPN) and paternal (pPN) pronucleus during pronuclear development. 5mC, in blue, was 
clearly present throughout pronuclear development in both the mPN and the pPN. The mPN was identified by H3K9me3 immunostaining (in 
green). The DNA was stained by EthD-2 (in red). All the images were taken at 630× and the scale bar represents 20 μm
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The presence of 5mC and 5hmC was evaluated by 
immunofluorescent staining in individual embryos. 
Although this is a very powerful tool to study the global 
changes in 5mC and 5hmC levels, the results are highly 
influenced by the protocol used, with the proper expo-
sure of the epitopes and the optimal incubation time and 
concentration of the primary antibodies being of major 
importance [18]. For example, it has been demonstrated 
in mouse zygotes that a reduction in the concentration 
of 5hmC primary antibody resulted in a reduced signal 
in the mPN [18], and the incubation with 5hmC primary 
antibody for longer than 1  h at room temperature or 
shorter than 6  h at 4  °C resulted in higher levels in the 
pPN than in the mPN, while these differences were no 
longer observed when saturation binding conditions were 
used [17]. Additionally, when epitopes are retrieved using 
the traditional acid-based method, an active demethyla-
tion in mouse zygotes is observed resulting in complete 
DNA demethylation of the pPN as early as 8 h after fer-
tilization [4, 11, 15, 23, 26]. However, if a new method to 
retrieve the 5mC epitope in mice is used, which combines 
the traditional acid treatment with a short tryptic diges-
tion, high levels of 5mC in both pronuclei throughout 
pronuclear development are observed instead of the 
active demethylation of the pPN [22].
To overcome this bias, we optimized the immunofluo-
rescent staining in equine zygotes in a previous study, 
in which the traditional acid treatment (4  N HCl) was 
compared to the new epitope retrieval method (4  N 
HCl + tryptic digestion) to evaluate the dynamics of 5mC 
and 5hmC and no significant differences between both 
methods were observed [27]. The new epitope retrieval 
method was chosen in this case because it reduces the 
acid treatment time by half. Furthermore, the optimal 
concentration and incubation time for the primary anti-
bodies were determined.
The different accessibility of 5mC and 5hmC antibod-
ies to the DNA depending on its parental origin in the 
mouse, evidenced by the asymmetric pattern of this 
marks observed between the mPN and pPN after short 
incubation with the primary antibodies or different 
epitope retrieval methods, indicates a different chro-
matin conformation depending on its parental origin. 
Indeed, the paternal DNA undergoes massive changes 
during pronuclear development, which might explain the 
different conformation. In the horse, however, this pos-
sible asymmetric chromatin conformation does not affect 
the binding of 5mC and 5hmC antibodies.
During the first cell cycle, DNA replication takes place 
[25] and the size and complexity of the pronuclei vary 
enormously, which renders fluorescence intensity quan-
tification even more challenging. In order to minimize 
these influences, we carefully classified the collected 
zygotes into four different pronuclear stages, based on 
the size and the conformation of their pronuclei. Addi-
tionally, the normalized fluorescence of 5mC or 5hmC 
was calculated for each pronucleus to correct for DNA 
replication.
In this study, we found no evidence of active DNA 
demethylation of the pPN in the horse. 5mC was highly 
present in both the mPN and pPN throughout pronuclear 
development. In the mPN, we found only increased nor-
malized 5mC levels between PN1 and PN2, but no differ-
ences were further found with PN3 and PN4, reflecting 
stable normalized 5mC levels from PN1 to PN4. These 
observations are in contrast to the classic model of global 
methylation erasure of the pPN during the first cell cycle 
as established in mouse [4] and conserved in human [7, 
11] and rat [6, 28]. However, they are in line with the 
results obtained in other species including rabbits [8, 24], 
sheep [11], pigs [9] and goats [10], where no loss of meth-
ylation was reported neither in the pPN or the mPN dur-
ing the first cell cycle.
At first, 5hmC was considered as being only an inter-
mediate form for DNA demethylation through TET 
oxidation [12]. This hypothesis was supported by the 
Fig. 5 Distribution of 5-methylcytosine (5mC) and 5-hydroxymethyl-
cytosine (5hmC) within the pronucleus. Single images were obtained 
at different positions of the same pronucleus from z-stacks to illus-
trate the distribution of 5mC and 5hmC. The pattern of distribution of 
5mC and 5hmC differs largely, with 5hmC being distributed homoge-
neously, while 5mC was concentrated in specific DNA regions. 5mC 
and 5hmC were evaluated in different zygotes
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Fig. 6 Dynamics of global DNA methylation in the paternal (pPN) and the maternal (mPN) pronucleus. In the pPN, no differences were found 
either in the normalized 5mC (5mC/DNA) or in the total DNA fluorescence (DNA) between pronuclear stages. However, an increase in the total 5mC 
fluorescence (5mC) was observed between PN1 and PN2. In the mPN, an increase in the normalized 5mC (5mC/DNA) was found between PN1 
and PN2. Similarly, an increase in the total 5mC fluorescence (5mC) was found between PN1 and PN2–PN3–PN4, and in the total DNA fluorescence 
(DNA) between PN1 and PN3. Finally, higher levels of normalized 5mC (5mC/DNA) were found in the mPN than the pPN at PN3 (*). The distribution 
of the 60 embryos included in the study was: PN1 (n = 6), PN2 (n = 25), PN3 (n = 18) and PN4 (n = 11). Different superscripts (a or b) indicate signifi-
cant differences, and p values <0.05 were considered significant
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observed inverse patterns between 5mC and 5hmC 
reported in mouse, rabbit and bovine zygotes, where 
increasing 5hmC levels in the pPN was accompanied by 
decreasing 5mC levels [5, 15, 29]. Nevertheless, it must 
be mentioned that some studies in mouse, using different 
immunostaining protocols, were not able to confirm this 
inverse pattern [16, 17]. Also in this study, this inverse 
relationship between 5mC and 5hmC was not observed, 
and 5mC as well as 5hmC coexisted in both the mPN 
and pPN throughout pronuclear development in the 
horse. Even though 5mC and 5hmC levels were not stud-
ied within the same embryo, and consequently, we were 
not able to correlate the dynamics of both marks, we 
did observe a completely different distribution pattern. 
While 5mC seemed more concentrated in some DNA 
regions, 5hmC was homogeneously distributed in the 
pronuclear DNA. This different distribution pattern of 
5mC and 5hmC has also been observed in cleavage stage 
embryos in the mouse, especially in the emerging pluri-
potent lineage where the presence of 5mC was restricted 
to some intensely stained foci [30]. This asymmetric pat-
tern might be a consequence of the strong association of 
5mC to heterochromatin, while 5hmC is preferentially 
associated with euchromatin [30]. Moreover, this finding 
also supports the growing evidence that 5hmC plays its 
own epigenetic role [16, 17, 31, 32].
It has been previously reported in mice, rabbit and cattle 
[5, 15, 16] that 5hmC is only present (or present in a con-
sistent higher level) in the pPN compared to its maternal 
counterpart. This was not observed in the horse, where 
high levels of 5hmC were found in both mPN and pPN. 
In this study, higher levels of 5hmC were demonstrated in 
Fig. 7 5-Hydroxymethylcytosine (5hmC) patterns in the maternal (mPN) and paternal (pPN) pronucleus during pronuclear development. 5hmC, in 
green, was clearly present throughout pronuclear development in both the mPN and the pPN. The parental origin of the pronuclei was determined 
by H3K9me3 immunostaining (in blue) and the DNA was stained by EthD-2 (in red). All the images were taken at 630×. The scale bar represents 
20 μm
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Fig. 8 Dynamics of global DNA hydroxymethylation in the paternal (pPN) and the maternal (mPN) pronucleus. No differences in the normalized 
levels of 5hmC (5hmC/DNA) were observed between the pronuclear stages in pPN or the mPN. However, the levels of normalized 5hmC were sig-
nificantly higher in the maternal PN2 than its paternal counterpart and in the paternal PN3 than its maternal counterpart (*). A significant increase 
in the levels of total 5hmC (5hmC) was found in the pPN between PN1 versus PN3 and in the mPN between PN1 vs. PN2–PN3–PN4. Additionally, a 
significant increase in the total DNA fluorescence (DNA) was observed between PN1 and PN3–PN4, in both pPN and mPN. The distribution of the 
81 embryos included in the study was: PN1 (n = 13), PN2 (n = 34), PN3 (n = 19) and PN4 (n = 15). Different superscripts (a or b) indicate significant 
differences, and p values <0.05 were considered significant
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the maternal PN2 compared to the paternal counterpart 
and vice versa in PN3: This is probably due to an intrinsic 
artifact of the fluorescence intensity quantification rather 
than to a biological explanation, especially when consid-
ering the high complexity of the pronuclei. Additionally, 
no differences  were observed in normalized 5hmC lev-
els between pronuclear stages regardless of the parental 
origin of the pronuclei in the horse, evidencing a stable 
presence of 5hmC during pronuclear development. This 
persistent level of 5hmC throughout pronuclear devel-
opment in both pPN and mPN has also been reported in 
mouse [17] and human [19].
In cattle, a strong association between the pattern of 
H3K9me3 and of 5mC in the pPN was reported, where 
during pronuclear development, the presence of both 
marks simultaneously increased in the pPN [33]. It was 
hypothesized that de novo H3K9 methylation directed 
the de novo DNA methylation, and as such, in cattle, 
global demethylation of the pPN is followed by a gradual 
H3K9 methylation and finally DNA methylation [33]. 
In the horse, this association was not observed. Instead, 
5mC levels remained high and constant during pronu-
clear development in the pPN, with no evidence of dem-
ethylation, while H3K9me3 was never present in the 
pPN, as previously demonstrated in the horse [20] and 
rabbit zygotes [24].
In conclusion, there is no evidence of global demethyla-
tion, nor active nor passive, in the horse during the first 
cell cycle. The normalized 5mC levels were high and sta-
ble during pronuclear development, showing no evidence 
of passive demethylation associated with DNA replica-
tion in the PN regardless their parental origin. Moreover, 
no evidence of active demethylation (replication inde-
pendent and TET mediated) was observed as stable and 
non-complementary patterns of normalized 5mC and 
5hmC were present in both PN during pronuclear devel-
opment. However, it is important to keep in mind that 
the embryos used in this study were produced in vitro by 
ICSI. In some species, such as rabbit [24] and rat [28], the 
loss of methylation observed by immunostaining in the 
pPN of in vivo-derived zygotes, was reduced after in vitro 
culture [24], IVF [28] and more dramatically after ICSI 
[28]. In sheep [11] and cattle [34], on the other hand, no 
differences in DNA methylation patterns were observed 
between in  vivo and IVF [11, 34] or ICSI [34] zygotes 
using the same immunostaining technique. In mouse, 
reduced loss of methylation of the pPN was observed 
after IVF when the acid-based epitope retrieval was 
used for immunostaining. When the acid-tryptic-based 
epitope retrieval was used instead, no differences in DNA 
methylation pattern were observed between in  vivo-
derived and in vitro-produced mouse zygotes, with both 
mPN and pPN showing high levels of DNA methylation 
[22]. Whether the results of this study apply for equine 
in  vivo zygotes as well remains to be investigated. The 
collection of equine zygotes in vivo is challenging, since 
the horse is a monovulatory species that not responds 
to superovulation and as such, only one zygote at a time 
could be on average surgically collected. On the other 
hand, the ICSI protocol used in this study yields a 20% 
blastocyst rate, which is in line with the results obtained 
by other groups [35]. Additionally, healthy foals have 
been born from embryos produced using this protocol. 
Consequently, an active demethylation of the pPN during 
first cell cycle might not be essential to obtain normal, 
healthy offspring in the horse. In line with this observa-
tion, the use of round spermatid injection (ROSI) in mice 
leads to similar high levels of 5mC in the pPN and the 
mPN, with the zygotes being still able to develop to term 
[36]. This indicates that active demethylation of the pPN 
is not essential for normal embryo development in the 
mouse as well.
Conclusions
In the present study, we described, for the first time in 
the horse, the global dynamics of DNA methylation 
and hydroxymethylation throughout pronuclear devel-
opment, independently in the paternal and maternal 
genome.
No evidence of active demethylation of the pater-
nal genome was found in the horse. Instead, 5mC and 
5hmC coexisted at high levels in both parental genomes 
throughout pronuclear development. Moreover, 5mC 
and 5hmC displayed different distribution patterns in the 
pronuclei with 5hmC homogeneously distributed, while 
5mC was more clustered within certain DNA regions. 
This suggests that both marks provide their own epige-
netic information. Considering these results, global DNA 
demethylation during the first cell division might not be 
essential for embryo development in the horse.
Methods
Equine in vitro embryo production
Equine zygotes were produced in  vitro by piezo drill-
assisted ICSI as described previously [37]. Briefly, 
ovaries were collected from slaughtered mares and pro-
cessed within 4  h. Cumulus oocyte complexes (COCs) 
were aspirated from follicles larger than 5  mm using a 
16-gauge needle attached to a vacuum pump (−100 mm 
Hg) and matured in groups of maximum 30 in 500 µL of 
Dulbecco’s modified Eagle medium nutrient mixture F-12 
(DMEM/F12; Gibco)-based maturation medium [38] for 
minimum 25 h at 38.5 °C in a humidified atmosphere of 
5% CO2 in air. After maturation, COCs were denuded 
by gentle pipetting in 0.05% bovine hyaluronidase 
(Sigma-Aldrich) for two minutes, followed by further 
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pipetting in HEPES-buffered TCM199 medium (Gibco) 
supplemented with 10% fetal bovine serum (FBS). Only 
oocytes with an extruded polar body were used for piezo 
drill-assisted ICSI. Frozen and fresh sperm of two dif-
ferent stallions was used for ICSI; after Percoll gradient 
centrifugation, the sperm was washed and kept in cal-
cium-free TALP and manipulated in 9% polyvinylpyr-
rolidone (Sigma-Aldrich) in phosphate-buffered saline 
(PBS, Gibco). All manipulations were performed on the 
heated stage (37  °C) of an inverted microscope; a pro-
gressively motile sperm was immobilized by piezo pulses 
and subsequently injected into the cytoplasm of a mature 
oocyte using a piezo drill. The injected oocytes were cul-
tured in groups of 10–15 in 20  μl drops of DMEM-F12 
supplemented with 10% FBS (Greiner Bio-One) and 
50 µg/ml Gentamycin (Sigma) at 38.2 °C in a humidified 
atmosphere of 5% CO2, 5% O2 and 90% N2. Presumptive 
zygotes were collected after 8, 11, 15, 19 and 23 h of cul-
ture in order to obtain all the pronuclear stages.
Immunofluorescent staining
After collection, presumptive zygotes were vortexed for 
1  min to remove any remaining cumulus cells, fixed in 
4% paraformaldehyde (PFA; Sigma-Aldrich) for 20 min at 
room temperature and kept in 2% PFA at 4 °C for a maxi-
mum of four days until immunostaining was performed. 
The zygotes were subsequently washed in PBS containing 
0.5% bovine serum albumin (BSA, Sigma-Aldrich) for 1 h 
at room temperature. After washing, they were permeabi-
lized with 0.5% Triton X-100 (Sigma-Aldrich) and 0.05% 
Tween 20 (Sigma-Aldrich) in PBS for 1 h at room tem-
perature, and washed three times for 5 min in 0.5% BSA 
in PBS. Zygotes were blocked in PBS containing 2% BSA 
for 1 h at room temperature and washed three times for 
2 min in 0.5% BSA in PBS. After washing, they were incu-
bated with the primary antibody rabbit anti-H3K9me3 
(1:100, Active Motif ) in 2% BSA in PBS overnight at 4 °C. 
Simultaneously, four zygotes were incubated with the 
non-immune control antibody rabbit IgG (0.01  mg/ml; 
Rockland 011-0102) in 2% BSA in PBS overnight at 4 °C. 
Zygotes which served as negative control remained in 2% 
PBS in BSA without adding any primary antibody. Next, 
all zygotes, including the non-immune and the nega-
tive control, were washed three times for 10 min in 0.5% 
BSA in PBS, post-fixed in 4% PFA for 25 min and washed 
again three times in 0.5% BSA in PBS for 10 min. Epitope 
retrieval was performed as described previously [20] by 
treating the zygotes with 4  N HCL (Sigma-Aldrich) for 
30 min at room temperature and with 100 mM Tris–HCl 
(pH 8.5; Sigma-Aldrich) for 10 min at room temperature, 
followed by three times washing with 5% BSA in PBS 
for 5-min and 20-s treatment with 0.25% (w/v) trypsin 
(Sigma-Aldrich T4799) at 37  °C. Tryptic digestion was 
stopped by incubating the zygotes with 30% goat serum 
(Gibco) in PBS for 2 min at room temperature and subse-
quently washing them three times with 0.5% BSA in PBS 
for 5  min. After epitope retrieval, zygotes were treated 
with 1  mg/mL RNase A (Affymetrix) for 30  min at 
37 °C to avoid the binding of the nuclear stain, ethidium 
homodimer 2 (EthD-2; Molecular Probes), to RNA [39]. 
Subsequently, they were washed three times in 0.5% BSA 
in PBS for 5  min and incubated with the nuclear stain 
0.5 nM EthD-2 in 0.5% BSA in PBS for 30 min at room 
temperature. After four washing steps of 2  min in 0.5% 
BSA in PBS, zygotes were incubated in blocking solu-
tion overnight at 4  °C. Subsequently, zygotes previously 
incubated with rabbit anti-H3K9me3 were incubated 
with either mouse anti-5mC (0.01  mg/ml; EpiGentek 
A-1014-050) or mouse anti-5hmC (0.01  mg/ml; Active 
Motif 39999) primary antibodies in 30% goat serum in 
PBS overnight at 4  °C. At the same time, zygotes previ-
ously incubated with rabbit IgG control antibody were 
incubated with mouse IgG control antibody (0.01  mg/
ml; Sigma-Aldrich) in 30% goat serum in PBS overnight 
at 4  °C. Zygotes used as negative control were placed in 
30% goat serum in PBS without the addition of primary 
antibodies. After incubation with the primary antibodies, 
zygotes were washed and serially incubated with the two 
secondary antibodies in 30% goat serum in PBS, for 1 h at 
room temperature each. For the H3K9me3-5mC immu-
nostaining, goat anti-rabbit FITC (0.02 mg/ml; Life Tech-
nologies) and goat anti-mouse Alexa Fluor 405 (0.02 mg/
ml; Abcam) secondary antibodies were used, respectively. 
For the H3K9me3-5hmC immunostaining, goat anti-rab-
bit Alexa Fluor 405 (0.02 mg/ml; Abcam) and goat anti-
mouse Alexa Fluor 488 (0.02 mg/ml; Abcam) secondary 
antibodies were used, respectively. After four washes of 
5  min in 0.5% BSA in PBS, two zygotes were mounted 
per slice in 24.7  mg/ml 1,4-diazabicyclo[2.2.2]octane 
(DABCO; Sigma-Aldrich) in 90% glycerol and 10% PBS, 
to prolong the lifetime of the dyes.
Fluorescence microscopy and image analysis
To avoid fading, evaluation of the embryos was per-
formed 2  days after immunostaining was completed, 
using a Leica TSC SPE-II confocal microscope (Leica, 
Belgium) with an ACS APO 63× oil immersion objec-
tive (Leica) and laser lines at 405, 488 and 561  nm 
wavelengths.
For each wavelength, single images were taken inde-
pendently of the equatorial cross section of each pro-
nucleus. Additionally, digital optical sections of the area 
containing both pronuclei were taken for each wave-
length using Z-series acquisition feature every 0.5 µm.
Quantitative analysis of fluorescence intensities was 
performed using the ImageJ software.
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The area of the equatorial cross section of each pro-
nucleus was manually outlined and measured in the sin-
gle images. After subtracting the background, the mean 
fluorescence intensity was measured for 5mC, 5hmC 
and EthD-2. The mean fluorescence intensities were then 
multiplied by the pronuclear areas to obtain the total 
fluorescence of 5mC, 5hmC and EthD-2. Finally, for each 
pronucleus, the total fluorescence of 5mC or 5hmC was 
divided by the total fluorescence of EthD-2 to obtain the 
normalized fluorescence.
When a small part of the mPN and pPN was overlap-
ping, the overlapping area was not measured. Addi-
tionally, when most of the area of the pronuclei was 
overlapping and the analysis of both pronuclei could not 
be made independently, the zygotes were excluded from 
the study.
Statistical analysis
Four replicates were performed for 5mC and 5hmC. The 
Kruskal–Wallis H test combined with Bonferroni correc-
tion for multiple testing was used to compare the total 
and normalized fluorescence between the different pro-
nuclear stages, independently for the mPN and pPN. The 
paired samples t test was used to compare the size and 
the normalized fluorescence between the mPN and the 
pPN in each pronuclear stage. All the analyses were per-
formed with SPSS Statistics 24 and p values <0.05 were 
considered significant.
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